Macrophage apoptosis in atherosclerosis: Consequences on plaque progression and the role of endoplasmic reticulum stress

Antioxidants and Redox Signaling

Volumn 11, Issue 9, 2009, Pages 2333-2339

  Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL CYCLE; ENDOPLASMIC RETICULUM STRESS; HUMAN; MACROPHAGE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; ATHEROSCLEROSIS; ENDOPLASMIC RETICULUM; HUMANS; MACROPHAGES; OXIDATIVE STRESS;

EID: 68949204491     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2469     Document Type: Review

References (52)

1. Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A, Bookout AL, Mak PA, Edwards PA, Mangelsdorf DJ, Tontonoz P, and Miyazaki T. A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development. Cell Metab 1: 201-213, 2005.
2. Ball RY, Stowers EC, Burton JH, Cary NR, Skepper JN, and Mitchinson MJ. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 114: 45-54, 1995.
3. Brown MS, Ho YK, and Goldstein JL. The cholesteryl ester cycle in macrophage foam cells: continual hydrolysis and reesterification of cytoplasmic cholesteryl esters. J Biol Chem 255: 9344-9352, 1980.
4. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, and Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24: 1266-1271, 2004.
5. Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR, and Tabas I. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82: 1040-1050, 2007.
6. DeVries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, Flavell R, and Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol 171: 61-73, 2005.
7. Edinger AL and Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16: 663-669, 2004.
8. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, and Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898, 1998.
9. Fadok VA, McDonald PP, Bratton DL, and Henson PM. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans 26: 653-656, 1998.
10. Fazio S, Major AS, Swift LL, Gleaves LA, Accad M, Linton MF, and Farese RV Jr. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 107: 163-171, 2001.
11. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, and Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5: 781-792, 2003.
12. Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, and Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci U S A 100: 10423-10428, 2003.
13. Glass CK and Witztum JL. Atherosclerosis. the road ahead. Cell 104: 503-516, 2001.
14. Han S, Liang CP, DeVries-Seimon T, Ranalletta M, Welch CL, Collins-Fletcher K, Accili D, Tabas I, and Tall AR. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3: 257-266, 2006.
15. Henson PM, Bratton DL, and Fadok VA. Apoptotic cell removal. Curr Biol 11: R795-R805, 2001.
16. Imoto K, Hiro T, Fujii T, Murashige A, Fukumoto Y, Hashimoto G, Okamura T, Yamada J, Mori K, and Matsuzaki M. Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J Am Coll Cardiol 46: 1507-1515, 2005.
17. Katz SS, Shipley GG, and Small DM. Physical chemistry of the lipids of human atherosclerotic lesions: demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest 58: 200-211, 1976.
18. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 1389-1398, 2002.
19. Li Y, Ge M, Ciani L, Kuriakose G, Westover E, Dura M, Covey D, Freed JH, Maxfield FR, Lytton J, and Tabas I. Enrichment of endoplasmic reticulum with cholesterol inhibits SERCA2b activity in parallel with increased order of membrane lipids: implications for depletion of ER calcium stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem 279: 37030-37039, 2004.
20. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, and Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7: 330-335, 1996.
21. Lim WS, Timmins JM, Seimon TA, Sadler A, Kolodgie FD, Virmani R, and Tabas I. STAT1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation 117: 940-951, 2008.
22. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, and Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 318: 944-949, 2007.
23. Liu J, Thewke DP, Su YR, Linton MF, Fazio S, and Sinensky MS. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 25: 174-179, 2005.
24. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
25. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Varez-Leite JI, de Winther MP, Tabas I, and Freeman MW. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 29: 19-26, 2009.
26. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J, Brady HR, and Godson C. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13: 2497-2507, 2002.
27. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K, Asada Y, Okada K, Ishibashi-Ueda H, Gabbiani G, Bochaton-Piallat ML, Mochizuki N, and Kitakaze M. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116: 1226-1233, 2007.
28. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, and Kassalow LM. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354: 1253-1263, 2006.
29. Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, and Austin RC. Characterization of the stress-inducing effects of homocysteine. Biochem J 332: 213-221, 1998.
30. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun CZ, and Hotamisligil GS. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140, 2006.
31. Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest 110: 1383-1388, 2002.
32. Schrijvers DM, De Meyer GR, Herman AG, and Martinet W. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 73: 470-480, 2007.
33. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, and Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25: 1256-1261, 2005.
34. Seimon T and Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res (in press).
35. Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, and Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A 103: 19794-19799, 2006.
36. Seimon T, Wang Y, Kuriakose G, Han S, Senokuchi T, Tall A, and Tabas I. Deficiency of p38a in macrophages promotes apoptosis and plaque necrosis in advanced murine atherosclerotic lesions. J Clin Invest 119: 886-898, 2009.
37. Senokuchi T, Liang CP, Seimon TA, Han S, Matsumoto M, Banks AS, Paik JH, Depinho RA, Accili D, Tabas I, and Tall AR. FoxOs promote apoptosis of insulin resistant macrophages during cholesterol-induced ER stress. Diabetes (in press).
38. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, and Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92: 8264-8268, 1995.
39. Steinberg D. Lipoproteins and atherosclerosis: a look back and a look ahead. Arteriosclerosis 3: 283-301, 1983.
40. Szegezdi E, Logue SE, Gorman AM, and Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880-885, 2006.
41. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 25: 2255-2264, 2005.
42. Tabas I. Mouse models of apoptosis and efferocytosis. Curr Drug Targets 8: 1288-1296, 2008.
43. Tabas I, Williams KJ, and Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116: 1832-1844, 2007.
44. Tardif JC, Gregoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lesperance J, Blue J, Heinonen T, and Rodes-Cabau J. Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110: 3372-3377, 2004.
45. Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, and Tabas I. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice. Circulation 116: 2182-2190, 2007.
46. -/- mice lacking CHOP. Cell Metab 2009 (in press).
47. Virmani R, Burke AP, Kolodgie FD, and Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15: 439-446, 2002.
48. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, and Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 270: 5772-5778, 1995.
49. Yao PM and Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J Biol Chem 275: 23807-23813, 2000.
50. Yao PM and Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 276: 42468-42476, 2001.
51. Zhou J, Lhotak S, Hilditch BA, and Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111: 1814-1821, 2005.
52. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, and Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982-995, 1998.